Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/65742
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2020-12-15T09:05:03Z | - |
dc.date.available | 2020-12-15T09:05:03Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Mifsud Buhagiar, L., Vella, K., Serracino-Inglott, A., & Gauci, C. (2020). Cannabis for medicinal purposes : legislative, regulatory and clinical implications. American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/65742 | - |
dc.description.abstract | Medicinal cannabis entails evolving dynamics, marked by considerations of therapeutic potential and safety concerns, ambivalent perceptions and scientific evidence, alongside accessibility issues tantamount to limited harmonisation across jurisdictions. Cannabis for medicinal purposes is largely regulated by provisions implemented on a State-by-State basis. The Laws of Malta were amended in 2018, enabling the prescribing of cannabis-based products manufactured under Good Manufacturing Practice (GMP). The national legislative amendments present an opportunity to assess the implications of regulatory requirements for controlled, quality medicinal cannabis products and to examine local predispositions in prescribing and clinical use. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Department of Pharmacy | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Cannabis -- Health aspects | en_GB |
dc.subject | Cannabis -- Therapeutic use | en_GB |
dc.subject | Cannabis -- Malta | en_GB |
dc.subject | Drug legalization -- Malta | en_GB |
dc.subject | Drug legalization -- Malta -- Public opinion | en_GB |
dc.title | Cannabis for medicinal purposes : legislative, regulatory and clinical implications | en_GB |
dc.type | presentation | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.bibliographicCitation.conferencename | American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition | en_GB |
dc.bibliographicCitation.conferenceplace | 6-10/12/2020 | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.contributor.creator | Mifsud Buhagiar, Luana | - |
dc.contributor.creator | Vella, Kristina | - |
dc.contributor.creator | Serracino-Inglott, Anthony | - |
dc.contributor.creator | Gauci, Charmaine | - |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cannabis for Medicinal Purposes - Legislative, Regulatory and Clinical Implications.pdf | 797.54 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.